June 25, 2021
Nacif et al v. Athira Pharma Inc et al
Case Number:
2:21-cv-00861
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Badgley Mullins
- Bernstein Litowitz
- Block & Leviton
- Breskin Johnson
- Byrnes Keller
- DLA Piper
- Glancy Prongay
- Keller Rohrback
- Labaton Keller
- Longman Law PC
- Perkins Coie
- Tousley Brain
- Wilson Sonsini
Companies
- Athira Pharma
- Jefferies Financial Group Inc.
- JMP Group Inc.
- Stifel Financial Corp.
- The Goldman Sachs Group Inc.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
November 04, 2024
Errors Lower Fee Award For Athira Pharma Investors' Counsel
A Seattle federal judge has awarded $2 million in attorney fees to four firms that represented a class of Athira Pharma investors following a $10 million settlement over allegations the company's former CEO manipulated Alzheimer's drug studies, trimming the 25% fee award the firms sought due to an "overall lack of success in this litigation."
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login